Next Article in Journal
New Irradiation Method with Indocyanine Green-Loaded Nanospheres for Inactivating Periodontal Pathogens
Previous Article in Journal
IQGAP1 in Podosomes/Invadosomes Is Involved in the Progression of Glioblastoma Multiforme Depending on the Tumor Status
Previous Article in Special Issue
EGFR and KRAS Mutations Predict the Incidence and Outcome of Brain Metastases in Non-Small Cell Lung Cancer
Open AccessReview

Breast Cancer Brain Metastases: Clonal Evolution in Clinical Context

The University of Queensland (UQ), UQ Centre for Clinical Research, Herston, Queensland 4029, Australia
QIMR Berghofer Medical Research Institute, Herston, Queensland 4006, Australia
Pathology Queensland, Royal Brisbane Women’s Hospital, Herston, Queensland 4029, Australia
UQ School of Medicine, Herston, Queensland 4006, Australia
Author to whom correspondence should be addressed.
Academic Editor: Dario Marchetti
Int. J. Mol. Sci. 2017, 18(1), 152;
Received: 8 November 2016 / Revised: 22 December 2016 / Accepted: 27 December 2016 / Published: 13 January 2017
(This article belongs to the Special Issue Brain Metastasis 2016)
Brain metastases are highly-evolved manifestations of breast cancer arising in a unique microenvironment, giving them exceptional adaptability in the face of new extrinsic pressures. The incidence is rising in line with population ageing, and use of newer therapies that stabilise metastatic disease burden with variable efficacy throughout the body. Historically, there has been a widely-held view that brain metastases do not respond to circulating therapeutics because the blood-brain-barrier (BBB) restricts their uptake. However, emerging data are beginning to paint a more complex picture where the brain acts as a sanctuary for dormant, subclinical proliferations that are initially protected by the BBB, but then exposed to dynamic selection pressures as tumours mature and vascular permeability increases. Here, we review key experimental approaches and landmark studies that have charted the genomic landscape of breast cancer brain metastases. These findings are contextualised with the factors impacting on clonal outgrowth in the brain: intrinsic breast tumour cell capabilities required for brain metastatic fitness, and the neural niche, which is initially hostile to invading cells but then engineered into a tumour-support vehicle by the successful minority. We also discuss how late detection, abnormal vascular perfusion and interstitial fluid dynamics underpin the recalcitrant clinical behaviour of brain metastases, and outline active clinical trials in the context of precision management. View Full-Text
Keywords: breast cancer; brain metastases; clonal evolution breast cancer; brain metastases; clonal evolution
Show Figures

Graphical abstract

MDPI and ACS Style

Saunus, J.M.; McCart Reed, A.E.; Lim, Z.L.; Lakhani, S.R. Breast Cancer Brain Metastases: Clonal Evolution in Clinical Context. Int. J. Mol. Sci. 2017, 18, 152.

AMA Style

Saunus JM, McCart Reed AE, Lim ZL, Lakhani SR. Breast Cancer Brain Metastases: Clonal Evolution in Clinical Context. International Journal of Molecular Sciences. 2017; 18(1):152.

Chicago/Turabian Style

Saunus, Jodi M.; McCart Reed, Amy E.; Lim, Zhun L.; Lakhani, Sunil R. 2017. "Breast Cancer Brain Metastases: Clonal Evolution in Clinical Context" Int. J. Mol. Sci. 18, no. 1: 152.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Search more from Scilit
Back to TopTop